King International Investment Limited

HK$0.85As of Sun 8 Nov 2026, 12:00 UTC
HKEX:0928Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR (21.71%)
Div yield —
ROE 0.80%
Diagnostics & Research
Beta (5Y) 0.78
PE TTM 85.30
TSR TTM (5.56%)
Mkt cap HK$157.3M
ROIC 1.02%
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.868
2.17%
(82.70%)
Sell 7|10|9|0|1
3Q26
4Q26
1Q27
2Q27
Earnings per share$
0.01
0.01
0.01
0.01
15.51%
11.49%
10.20%
(3.71%)
Revenue$M
15.71
15.30
15.92
16.06
(2.08%)
(7.66%)
(1.59%)
(0.44%)
Peers (US$18.88M)
Cap (US$)
PE
35.84M
4.009x
Capital
TTM
5Y
10Y
Leveragex
0.125
(0.021)
(0.018)
EBIT/Intx
0.254
0.419
0.323
Own earn%
(75.61)
67.64
96.48
Sh yield%
33.18
16.89
17.99
Owners
Insiders/Inst%
0.82
86.41
Short interest%
4.94
SBC / revenue%
1.81
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
9
Op margin range%
7–16
$1 testx
—
Incr. ROIC%
7